A discovery offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins in ...

The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...

Jascayd (nerandomilast) is a brand-name prescription oral tablet used to treat idiopathic pulmonary fibrosis and progressive pulmonary fibrosis in adults by reducing inflammation and slowing lung ...

Breathing disorders are common in the U.S. with conditions like COPD affecting some 7% of the population and asthma affecting another 10%. Digestive conditions like GERD, acid reflux, Celiac disease ...

Dear Dr. Roach: My mother is 86 years old. She is in relatively good health. She recently saw her primary care physician for her routine checkup. Prior to her visit, she had developed cold symptoms.

NTU Singapore is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology ...